Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Apr;53(4):266–272. doi: 10.1136/jcp.53.4.266

Monitoring patients with HIV disease

M Helbert 1, J Breuer 1
PMCID: PMC1731179  PMID: 10823121

Full Text

The Full Text of this article is available as a PDF (146.6 KB).

graphic file with name 99198.f1.jpg

Open in a new tab

Figure 1 CD4 count centiles for normal children.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amasaki Y., Kobayashi S., Takeda T., Ogura N., Jodo S., Nakabayashi T., Tsutsumi A., Fujisaku A., Koike T. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol. 1995 Feb;99(2):245–250. doi: 10.1111/j.1365-2249.1995.tb05540.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bass H. Z., Hardy W. D., Mitsuyasu R. T., Wang Y. X., Cumberland W., Fahey J. L. Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr. 1992;5(9):890–897. [PubMed] [Google Scholar]
  3. Bass H. Z., Nishanian P., Hardy W. D., Mitsuyasu R. T., Esmail E., Cumberland W., Fahey J. L. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol. 1992 Jul;64(1):63–70. doi: 10.1016/0090-1229(92)90060-2. [DOI] [PubMed] [Google Scholar]
  4. Beck E. J., French P. D., Helbert M. H., Robinson D. S., Moss F. M., Harris J. R., Pinching A. J., Mitchell D. M. Improved outcome of Pneumocystis carinii pneumonia in AIDS patients: a multifactorial treatment effect. Int J STD AIDS. 1992 May-Jun;3(3):182–187. doi: 10.1177/095646249200300305. [DOI] [PubMed] [Google Scholar]
  5. Boucher C. A., Lange J. M., Miedema F. F., Weverling G. J., Koot M., Mulder J. W., Goudsmit J., Kellam P., Larder B. A., Tersmette M. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS. 1992 Nov;6(11):1259–1264. doi: 10.1097/00002030-199211000-00003. [DOI] [PubMed] [Google Scholar]
  6. Brew B. J., Dunbar N., Pemberton L., Kaldor J. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J Infect Dis. 1996 Aug;174(2):294–298. doi: 10.1093/infdis/174.2.294. [DOI] [PubMed] [Google Scholar]
  7. Burton A. H., Mertens T. E. Provisional country estimates of prevalent adult human immunodeficiency virus infections as of end 1994: a description of the methods. Int J Epidemiol. 1998 Feb;27(1):101–107. doi: 10.1093/ije/27.1.101. [DOI] [PubMed] [Google Scholar]
  8. Cameron P. U., Freudenthal P. S., Barker J. M., Gezelter S., Inaba K., Steinman R. M. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992 Jul 17;257(5068):383–387. doi: 10.1126/science.1352913. [DOI] [PubMed] [Google Scholar]
  9. Carpenter C. C., Fischl M. A., Hammer S. M., Hirsch M. S., Jacobsen D. M., Katzenstein D. A., Montaner J. S., Richman D. D., Saag M. S., Schooley R. T. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998 Jul 1;280(1):78–86. doi: 10.1001/jama.280.1.78. [DOI] [PubMed] [Google Scholar]
  10. Chailleux E., Bignon J. D., Peyrat M. A., Godard A., Soulillou J. P. Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis. Thorax. 1985 Oct;40(10):768–773. doi: 10.1136/thx.40.10.768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Condra J. H., Holder D. J., Schleif W. A., Blahy O. M., Danovich R. M., Gabryelski L. J., Graham D. J., Laird D., Quintero J. C., Rhodes A. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol. 1996 Dec;70(12):8270–8276. doi: 10.1128/jvi.70.12.8270-8276.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Daar E. S., Moudgil T., Meyer R. D., Ho D. D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Apr 4;324(14):961–964. doi: 10.1056/NEJM199104043241405. [DOI] [PubMed] [Google Scholar]
  13. Deeks S. G., Abrams D. I. Genotypic-resistance assays and antiretroviral therapy. Lancet. 1997 May 24;349(9064):1489–1490. doi: 10.1016/S0140-6736(05)62092-2. [DOI] [PubMed] [Google Scholar]
  14. Deeks S. G., Smith M., Holodniy M., Kahn J. O. HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997 Jan 8;277(2):145–153. [PubMed] [Google Scholar]
  15. Douek D. C., McFarland R. D., Keiser P. H., Gage E. A., Massey J. M., Haynes B. F., Polis M. A., Haase A. T., Feinberg M. B., Sullivan J. L. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998 Dec 17;396(6712):690–695. doi: 10.1038/25374. [DOI] [PubMed] [Google Scholar]
  16. Dunne J., Feighery C., Whelan A. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients. Br J Biomed Sci. 1996 Dec;53(4):263–269. [PubMed] [Google Scholar]
  17. Durant J., Clevenbergh P., Halfon P., Delgiudice P., Porsin S., Simonet P., Montagne N., Boucher C. A., Schapiro J. M., Dellamonica P. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet. 1999 Jun 26;353(9171):2195–2199. doi: 10.1016/s0140-6736(98)12291-2. [DOI] [PubMed] [Google Scholar]
  18. Ekong T., Kupek E., Hill A., Clark C., Davies A., Pinching A. Technical influences on immunophenotyping by flow cytometry. The effect of time and temperature of storage on the viability of lymphocyte subsets. J Immunol Methods. 1993 Sep 15;164(2):263–273. doi: 10.1016/0022-1759(93)90319-3. [DOI] [PubMed] [Google Scholar]
  19. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  20. Fowke K. R., D'Amico R., Chernoff D. N., Pottage J. C., Jr, Benson C. A., Sha B. E., Kessler H. A., Landay A. L., Shearer G. M. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS. 1997 Jul;11(8):1013–1021. doi: 10.1097/00002030-199708000-00010. [DOI] [PubMed] [Google Scholar]
  21. Furrer H., Egger M., Opravil M., Bernasconi E., Hirschel B., Battegay M., Telenti A., Vernazza P. L., Rickenbach M., Flepp M. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med. 1999 Apr 29;340(17):1301–1306. doi: 10.1056/NEJM199904293401701. [DOI] [PubMed] [Google Scholar]
  22. Gilquin J., Piketty C., Thomas V., Gonzales-Canali G., Belec L., Kazatchkine M. D. Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100 x 10(6) cells/l following combination antiretroviral therapy including protease inhibitors. AIDS. 1997 Nov;11(13):1659–1660. [PubMed] [Google Scholar]
  23. Ginocchio C. C., Wang X. P., Kaplan M. H., Mulligan G., Witt D., Romano J. W., Cronin M., Carroll R. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol. 1997 Nov;35(11):2886–2893. doi: 10.1128/jcm.35.11.2886-2893.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Goletti D., Weissman D., Jackson R. W., Graham N. M., Vlahov D., Klein R. S., Munsiff S. S., Ortona L., Cauda R., Fauci A. S. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol. 1996 Aug 1;157(3):1271–1278. [PubMed] [Google Scholar]
  25. Goodkin K., Feaster D. J., Asthana D., Blaney N. T., Kumar M., Baldewicz T., Tuttle R. S., Maher K. J., Baum M. K., Shapshak P. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol. 1998 May;5(3):382–391. doi: 10.1128/cdli.5.3.382-391.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Groux H., Torpier G., Monté D., Mouton Y., Capron A., Ameisen J. C. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med. 1992 Feb 1;175(2):331–340. doi: 10.1084/jem.175.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. CD4+ T lymphocyte Working Party. Members of the General Haematology Task Force of BCSH. Clin Lab Haematol. 1997 Dec;19(4):231–241. doi: 10.1046/j.1365-2257.1997.00091.x. [DOI] [PubMed] [Google Scholar]
  28. Hammer S. M., Katzenstein D. A., Hughes M. D., Gundacker H., Schooley R. T., Haubrich R. H., Henry W. K., Lederman M. M., Phair J. P., Niu M. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med. 1996 Oct 10;335(15):1081–1090. doi: 10.1056/NEJM199610103351501. [DOI] [PubMed] [Google Scholar]
  29. Havlir D. V., Richman D. D. The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy. Springer Semin Immunopathol. 1997;18(3):267–283. doi: 10.1007/BF00813498. [DOI] [PubMed] [Google Scholar]
  30. Helbert M. R., L'age-Stehr J., Mitchison N. A. Antigen presentation, loss of immunological memory and AIDS. Immunol Today. 1993 Jul;14(7):340–344. doi: 10.1016/0167-5699(93)90232-A. [DOI] [PubMed] [Google Scholar]
  31. Helbert M. T-cell receptor variable gene products and early HIV-1 infection. Lancet. 1992 May 23;339(8804):1299–1300. doi: 10.1016/0140-6736(92)91630-q. [DOI] [PubMed] [Google Scholar]
  32. Hertogs K., de Béthune M. P., Miller V., Ivens T., Schel P., Van Cauwenberge A., Van Den Eynde C., Van Gerwen V., Azijn H., Van Houtte M. A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother. 1998 Feb;42(2):269–276. doi: 10.1128/aac.42.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
  34. Hoover D. R. The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature. Drugs. 1995 Jan;49(1):20–36. doi: 10.2165/00003495-199549010-00003. [DOI] [PubMed] [Google Scholar]
  35. Jacobson M. A., Zegans M., Pavan P. R., O'Donnell J. J., Sattler F., Rao N., Owens S., Pollard R. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997 May 17;349(9063):1443–1445. doi: 10.1016/S0140-6736(96)11431-8. [DOI] [PubMed] [Google Scholar]
  36. Japour A. J., Mayers D. L., Johnson V. A., Kuritzkes D. R., Beckett L. A., Arduino J. M., Lane J., Black R. J., Reichelderfer P. S., D'Aquila R. T. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Antimicrob Agents Chemother. 1993 May;37(5):1095–1101. doi: 10.1128/aac.37.5.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kati W. M., Johnson K. A., Jerva L. F., Anderson K. S. Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem. 1992 Dec 25;267(36):25988–25997. [PubMed] [Google Scholar]
  38. Kempf D. J., Rode R. A., Xu Y., Sun E., Heath-Chiozzi M. E., Valdes J., Japour A. J., Danner S., Boucher C., Molla A. The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. AIDS. 1998 Mar 26;12(5):F9–14. doi: 10.1097/00002030-199805000-00001. [DOI] [PubMed] [Google Scholar]
  39. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994 Jul;68(7):4650–4655. doi: 10.1128/jvi.68.7.4650-4655.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Landay A., Ho J. L., Hom D., Russell T., Zwerner R., Minuty J. G., Kataaha P., Mmiro F., Jackson B. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993 Dec;7(12):1565–1568. doi: 10.1097/00002030-199312000-00004. [DOI] [PubMed] [Google Scholar]
  41. Larder B. A., Darby G., Richman D. D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989 Mar 31;243(4899):1731–1734. doi: 10.1126/science.2467383. [DOI] [PubMed] [Google Scholar]
  42. Liu Z., Hultin L. E., Cumberland W. G., Hultin P., Schmid I., Matud J. L., Detels R., Giorgi J. V. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry. 1996 Mar 15;26(1):1–7. doi: 10.1002/(SICI)1097-0320(19960315)26:1<1::AID-CYTO1>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  43. Loken M. R., Brosnan J. M., Bach B. A., Ault K. A. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry. 1990;11(4):453–459. doi: 10.1002/cyto.990110402. [DOI] [PubMed] [Google Scholar]
  44. Maini M. K., Gilson R. J., Chavda N., Gill S., Fakoya A., Ross E. J., Phillips A. N., Weller I. V. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med. 1996 Feb;72(1):27–31. doi: 10.1136/sti.72.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Masur H., Ognibene F. P., Yarchoan R., Shelhamer J. H., Baird B. F., Travis W., Suffredini A. F., Deyton L., Kovacs J. A., Falloon J. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989 Aug 1;111(3):223–231. doi: 10.7326/0003-4819-111-3-223. [DOI] [PubMed] [Google Scholar]
  46. Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, Todd J. A., Hoo B. S., Kokka R. P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995 Apr 15;122(8):573–579. doi: 10.7326/0003-4819-122-8-199504150-00003. [DOI] [PubMed] [Google Scholar]
  47. Mellors J. W., Rinaldo C. R., Jr, Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 May 24;272(5265):1167–1170. doi: 10.1126/science.272.5265.1167. [DOI] [PubMed] [Google Scholar]
  48. Miller V., Stürmer M., Staszewski S., Gröschel B., Hertogs K., de Béthune M. P., Pauwels R., Harrigan P. R., Bloor S., Kemp S. D. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors. AIDS. 1998 May 7;12(7):705–712. doi: 10.1097/00002030-199807000-00006. [DOI] [PubMed] [Google Scholar]
  49. Mocroft A., Bofill M., Lipman M., Medina E., Borthwick N., Timms A., Batista L., Winter M., Sabin C. A., Johnson M. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):158–162. doi: 10.1097/00042560-199702010-00009. [DOI] [PubMed] [Google Scholar]
  50. Nicholson J. K. Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and Prevention. Cytometry. 1994 Mar 15;18(1):55–59. doi: 10.1002/cyto.990180111. [DOI] [PubMed] [Google Scholar]
  51. Nicholson J. K., Jones B. M., Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry. 1993;14(6):685–689. doi: 10.1002/cyto.990140614. [DOI] [PubMed] [Google Scholar]
  52. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  53. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993 Mar 25;362(6418):355–358. doi: 10.1038/362355a0. [DOI] [PubMed] [Google Scholar]
  54. Perrin L., Telenti A. HIV treatment failure: testing for HIV resistance in clinical practice. Science. 1998 Jun 19;280(5371):1871–1873. doi: 10.1126/science.280.5371.1871. [DOI] [PubMed] [Google Scholar]
  55. Phillips A. N., McLean A., Johnson M. A., Tyrer M., Emery V., Griffiths P., Bofill M., Janossy G., Loveday C. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management. J Med Virol. 1997 Nov;53(3):261–265. [PubMed] [Google Scholar]
  56. Phillips A. N. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science. 1996 Jan 26;271(5248):497–499. doi: 10.1126/science.271.5248.497. [DOI] [PubMed] [Google Scholar]
  57. Quillent C., Oberlin E., Braun J., Rousset D., Gonzalez-Canali G., Métais P., Montagnier L., Virelizier J. L., Arenzana-Seisdedos F., Beretta A. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet. 1998 Jan 3;351(9095):14–18. doi: 10.1016/S0140-6736(97)09185-X. [DOI] [PubMed] [Google Scholar]
  58. Racz P., Tenner-Racz K., van Vloten F., Schmidt H., Dietrich M., Gluckman J. C., Letvin N. L., Janossy G. Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. Lymphology. 1990 Jun;23(2):85–91. [PubMed] [Google Scholar]
  59. Ritchie A. W., Oswald I., Micklem H. S., Boyd J. E., Elton R. A., Jazwinska E., James K. Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) 1983 Jun 4;286(6380):1773–1775. doi: 10.1136/bmj.286.6380.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Rose D. N., Sacks H. S. Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing. AIDS. 1997 Jun;11(7):883–887. doi: 10.1097/00002030-199707000-00007. [DOI] [PubMed] [Google Scholar]
  61. Røsok B., Voltersvik P., Bjerknes R., Axelsson M., Haaheim L. R., Asjö B. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals. Clin Exp Immunol. 1996 May;104(2):203–207. doi: 10.1046/j.1365-2249.1996.25732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Saag M. S., Holodniy M., Kuritzkes D. R., O'Brien W. A., Coombs R., Poscher M. E., Jacobsen D. M., Shaw G. M., Richman D. D., Volberding P. A. HIV viral load markers in clinical practice. Nat Med. 1996 Jun;2(6):625–629. doi: 10.1038/nm0696-625. [DOI] [PubMed] [Google Scholar]
  63. Shirasaka T., Kavlick M. F., Ueno T., Gao W. Y., Kojima E., Alcaide M. L., Chokekijchai S., Roy B. M., Arnold E., Yarchoan R. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2398–2402. doi: 10.1073/pnas.92.6.2398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Sloan-Lancaster J., Evavold B. D., Allen P. M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 1993 May 13;363(6425):156–159. doi: 10.1038/363156a0. [DOI] [PubMed] [Google Scholar]
  65. Tscherning C., Alaeus A., Fredriksson R., Björndal A., Deng H., Littman D. R., Fenyö E. M., Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology. 1998 Feb 15;241(2):181–188. doi: 10.1006/viro.1997.8980. [DOI] [PubMed] [Google Scholar]
  66. Ullum H., Palmø J., Halkjaer-Kristensen J., Diamant M., Klokker M., Kruuse A., LaPerriere A., Pedersen B. K. The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons. J Acquir Immune Defic Syndr. 1994 Nov;7(11):1122–1133. [PubMed] [Google Scholar]
  67. Valentine M. E., Jackson C. R., Vavro C., Wilfert C. M., McClernon D., St Clair M., Katz S. L., McKinney R. E., Jr Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J. 1998 Jan;17(1):18–23. doi: 10.1097/00006454-199801000-00005. [DOI] [PubMed] [Google Scholar]
  68. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
  69. Wong J. K., Günthard H. F., Havlir D. V., Zhang Z. Q., Haase A. T., Ignacio C. C., Kwok S., Emini E., Richman D. D. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12574–12579. doi: 10.1073/pnas.94.23.12574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Wong J. K., Hezareh M., Günthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., Richman D. D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997 Nov 14;278(5341):1291–1295. doi: 10.1126/science.278.5341.1291. [DOI] [PubMed] [Google Scholar]
  71. Zaknun D., DiFranco M., Oswald H. P., Zaknun J., Mayersbach P., Vuja E., Wachter H., Fuchs D. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children. Wien Klin Wochenschr. 1993;105(10):284–288. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES